Accelerating therapeutic discovery and enabling personalized medicine through the use of patient-derived cell models
Stem Cell Theranostics (SCT) is a biotechnology company dedicated to accelerating therapeutic discovery and enabling personalized medicine using patient-derived cell models.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 17, 2015 | Grant | $150K | 1 |
National Science Foundation
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Science Foundation
|
Yes | Grant |